In The News

Merrill Matthews Jr., Ph.D., a resident scholar at the Institute for Policy Innovation, credits two factors with driving U.S. energy dominance: property rights and technology.

IPI commends Sens. Patrick Leahy, D-Vt., and Mike Lee, R-Utah, for introducing the ECPA Modernization Act of 2017, which fixes a glaring hole in the Fourth Amendment privacy protections Americans should enjoy on their electronic data.

The Cruz-Lee provision in the Senate health care bill could allow people to return to the policies they once had—and many desperately wanted to keep—before Obamacare effectively outlawed them.

"Probably the best way to stabilize the markets is for states to shift to an invisible high-risk pool, as Alaska and Maine have done," Matthews said. "But it isn't entirely clear how well that works for larger states with multiple carriers. And it isn't clear Republicans will provide any money for that."

What’s surprising is that Texas — a state that has embraced a limited-government, free-market approach — still delegates and defers so much power to outdated regulatory agencies.

There is at least one sector where “Made in America” means a stronger economy — not a weaker one.

In comments filed today, IPI applauded the FCC’s Restoring Internet Freedom rulemaking, especially the agency’s reversal on the Wheeler FCC’s “most unfortunate and unnecessary error”-- the 2015 mistake of reclassifying broadband as a Title II common carrier communications service.

Senator Ted Cruz (R-TX), along with Senator Mike Lee (R-UT), may have the solution to the health care stalemate—and it just might allow a functioning health insurance market to emerge once again for most people.

In a Wall Street Journal opinion piece Sunday, Merrill Matthews of the conservative think tank Institute for Policy Innovation highlighted the differences in production and royalty rats between federal and state lands.

Prescription drug costs are a hot political issue, not as much because of the share of the U.S. health care dollar they consume but because consumers pay a larger share of their drug costs out of pocket than they do for other health care.